Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has announced its participation in several upcoming investor conferences.

Rhea-AI Summary

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has announced its participation in several upcoming investor conferences. Key events include:

• Stifel 2022 Virtual CNS Days on March 28, 2022
• Guggenheim Virtual Genomic Medicines and Rare Disease Day on April 1, 2022
• Needham 21st Annual Virtual Healthcare Conference on April 11, 2022
• Bank of America 2022 Healthcare Conference on May 11, 2022, in Las Vegas, NV

Live webcasts and replays will be available via the Ionis website. The company continues its commitment to RNA-targeted therapies with a robust pipeline.

Argus Session date unavailable

-0.94% session move Open Argus

Details

News Market Reaction – IONS

The recorded move for IONS in the trading session of this news was -0.94%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., March 21, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present at the following investor conferences:

• Stifel 2022 Virtual CNS Days on Monday, March 28, 2022
• Guggenheim Virtual Genomic Medicines and Rare Disease Day on Friday, April 1, 2022
• Needham 21^st Annual Virtual Healthcare Conference on Monday, April 11, 2022
• Bank of America 2022 Healthcare Conference on Wednesday, May 11, 2022, in Las Vegas, NV

A live webcast and additional information about each presentation can be accessed on the Investors & Media section of the Ionis website at www.ionispharma.com. Replays will be available on the Ionis website within 48 hours of each event.

About Ionis Pharmaceuticals

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully-integrated biotechnology company.

To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301505979.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences will Ionis Pharmaceuticals present at in 2022?

Ionis Pharmaceuticals will present at the Stifel 2022 Virtual CNS Days on March 28, Guggenheim Virtual Genomic Medicines and Rare Disease Day on April 1, Needham 21st Annual Virtual Healthcare Conference on April 11, and Bank of America 2022 Healthcare Conference on May 11.

Where can I find the live webcasts for Ionis Pharmaceuticals' presentations?

Live webcasts for Ionis Pharmaceuticals' presentations can be accessed on the Investors & Media section of their website at www.ionispharma.com.

Will Ionis Pharmaceuticals provide replays of the conference presentations?

Yes, Ionis Pharmaceuticals will offer replays of each conference presentation on their website within 48 hours after the events.

What is Ionis Pharmaceuticals known for?

Ionis Pharmaceuticals is known for being a leader in RNA-targeted therapy and has developed several marketed medicines along with a strong late-stage pipeline.

What is the stock symbol for Ionis Pharmaceuticals?

The stock symbol for Ionis Pharmaceuticals is IONS.